|Bid||40.90 x 1800|
|Ask||40.91 x 3100|
|Day's Range||40.71 - 41.02|
|52 Week Range||31.43 - 48.25|
|Beta (5Y Monthly)||0.40|
|PE Ratio (TTM)||41.27|
|Earnings Date||Feb 01, 2017 - Feb 06, 2017|
|Forward Dividend & Yield||1.89 (4.63%)|
|Ex-Dividend Date||May 14, 2020|
|1y Target Est||47.70|
Millions are pinning their hopes on a handful of drugmakers, which are into the final phases of their vaccine trial.
GlaxoSmithKline plc (LON:GSK) stock is about to trade ex-dividend in three days. This means that investors who...
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of GlaxoSmithKline plc and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.